What is the leading causative organism of epididymitis in men under 35 years old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Leading Causative Organisms of Epididymitis in Men Under 35

In men under 35 years of age, Chlamydia trachomatis is the leading causative organism of epididymitis, followed closely by Neisseria gonorrhoeae. 1, 2

Primary Pathogens by Age

Men Under 35 Years (Sexually Active)

  • Chlamydia trachomatis is the most common pathogen in this age group 1, 3, 4
  • Neisseria gonorrhoeae is the second most common causative organism 1, 3, 4
  • Both organisms cause sexually transmitted epididymitis that is typically accompanied by urethritis, which is often asymptomatic 1
  • Among men who practice insertive anal intercourse, sexually transmitted Escherichia coli infection also occurs 1

Men Over 35 Years

  • Gram-negative enteric organisms (particularly E. coli and other Enterobacteriaceae) predominate in this older age group 1, 5, 6
  • These infections are typically associated with urinary tract abnormalities, bladder outlet obstruction, or recent urinary tract instrumentation 1, 3

Clinical Context and Diagnostic Implications

The age cutoff of 35 years is critical for determining empiric treatment, as the microbiology shifts dramatically at this threshold 1, 3:

  • In sexually active men aged 14-35 years, urethritis is frequently present (even if asymptomatic), and diagnostic evaluation should include urethral swab testing for C. trachomatis and N. gonorrhoeae rather than relying solely on urinalysis 2, 7
  • Current tests for C. trachomatis are not sufficiently sensitive to exclude infection even when negative, so empiric treatment is warranted based on clinical presentation 1, 2

Treatment Implications

Because C. trachomatis and N. gonorrhoeae are the leading organisms in men under 35, the CDC recommends dual therapy:

  • Ceftriaxone 250 mg IM single dose PLUS doxycycline 100 mg orally twice daily for 10 days 1, 2, 7, 8
  • This regimen covers both organisms effectively, as C. trachomatis requires prolonged doxycycline therapy while N. gonorrhoeae is treated with the single-dose ceftriaxone 1, 3, 4

Important Caveats

  • Sex partners should be evaluated and treated empirically regardless of their symptoms, as male partners are frequently asymptomatic carriers 1
  • Partners who had sexual contact within 60 days preceding symptom onset require treatment 1, 7, 8
  • Failure to improve within 3 days of appropriate treatment requires reevaluation of both diagnosis and therapy, including consideration of testicular torsion, abscess, or other diagnoses 2, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Bacterial Epididymitis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Epididymitis: An Overview.

American family physician, 2016

Research

Epididymitis and orchitis: an overview.

American family physician, 2009

Research

[Orchi-epididymitis].

Annales d'urologie, 2003

Guideline

Epididymitis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Epididymitis vs Orchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.